Conterno Enrique A
Chief Executive Officer | SVP&Pres, Lillydiab &Lillyusa | Sr. VP &Pres., Lilly Diabetes
2 companies
Insider Signal Score
87
ExcellentTrades Analyzed
7
12M Win Rate
100.0%
Avg 3M Return
+33.8%
Avg 12M Return
+90.4%
Conterno Enrique A is a Chief Executive Officer at FIBROGEN INC with holdings across 2 companies. Recent SEC Form 4 filings include 2 buys and 12 sells.
Estimated insider holdings value: $159.1M based on current market prices.
Holdings by Company
Transaction History
Showing 10 filings
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jul 7, 2023 | KYNB Fibrogen Inc | Chief Executive Officer | Sell | 1,880 | $2.80 | $5,264.00 | -0.5% | -73.4% | -73.3% | |
| Jun 7, 2023 | KYNB Fibrogen Inc | Chief Executive Officer | Sell | 8,897 | $17.04 | $151,583.13 | -1.2% | -93.8% | -93.1% | |
| Apr 10, 2023 | KYNB Fibrogen Inc | Chief Executive Officer | Sell | 1,869 | $19.52 | $36,482.88 | -0.5% | -85.5% | -92.1% | |
| Mar 10, 2023 | KYNB Fibrogen Inc | Chief Executive Officer | Sell | 56,261 | $20.62 | $1,159,970.87 | -4.7% | -11.6% | -91.1% | |
| Jan 6, 2023 | KYNB Fibrogen Inc | Chief Executive Officer | Sell | 1,538 | $19.95 | $30,683.10 | -0.5% | -1.0% | -96.2% | |
| Dec 8, 2022 | KYNB Fibrogen Inc | Chief Executive Officer | Sell | 2,543 | $15.79 | $40,153.97 | -0.8% | +39.7% | -95.9% | |
| Jun 11, 2020 | KYNB Fibrogen Inc | Chief Executive Officer | Buy | 27,800 | $35.57 | $988,881.84 | +347.5% | - | - | |
| Feb 15, 2019 | LLY Eli Lilly & Co | SVP&Pres, Lillydiab &Lillyusa | Sell | 25,000 | $121.00 | $3,025,000.00 | -15.8% | - | - | |
| May 31, 2018 | LLY Eli Lilly & Co | SVP&Pres, Lillydiab &Lillyusa | Sell | 25,000 | $85.00 | $2,125,000.00 | -16.7% | - | - | |
| May 4, 2017 | LLY Eli Lilly & Co | SVP&Pres, Lillydiab &Lillyusa | Sell | 25,000 | $82.76 | $2,069,000.00 | -18.0% | - | - |
Page 1Next →